Which statement is true about the list of insulin types as described in the material?

• A. Lispro, Regular, Ultralente, and NPH are listed
• B. Glargine is listed as an insulin type in the material
• C. Regular insulin is the only short-acting option listed
• D. NPH insulin is not listed

Answer: (A)

Insulin preparations are classified by how long they act after injection, covering rapid, short, intermediate, and long-acting profiles. The material’s list includes lispro (rapid-acting), regular (short-acting), NPH (intermediate-acting), and ultralente (long-acting), demonstrating a full range of action durations. That makes the statement true because it directly reflects the four insulin types described.

Notes on the other ideas: glargine is another long-acting insulin, but it’s not mentioned in this material’s list, so claiming it is listed wouldn’t fit. Regular insulin is the standard short-acting option, but lispro is rapid-acting as well, so saying regular is the only short-acting option doesn’t match the described list. NPH is indeed listed, so stating that it’s not listed is inaccurate.